Liu, Prostate cancer antigen-1 as a potential novel marker for prostate cancer, Asian J. Androl. 9 (2007) 821-826.Liu BQ, Wu YD, Li PH, Wei JX, Zhang T, Liu RL. 2007. Prostate cancer antigen-1 as a potential novel marker for prostate cancer. Asian J Androl 9: 821-826.Liu BQ...
Several markers for dying from prostate cancer exist, but whether these are markers for telling who is likely to die early from any cause, and how their performance compares, is unknown. Identifying such a marker is important because we can then identify which men may benefit from new, more ...
An SLC18A2 gene serves as a marker of prostate cancer. Methods are provided for diagnosing prostate cancer, predicting or prognosticating the disease outcome, predicting recurrence following surgery, and monitoring disease progression in an individual having prostate cancer. The methods relate to ...
An SLC18A2 gene serves as a marker of prostate cancer. Methods are provided for diagnosing prostate cancer, predicting or prognosticating the disease outcome, predicting recurrence following surgery, and monitoring disease progression in an individual having prostate cancer. The methods relate to ...
A biomarker is a biological molecule that can be detected in physiological fluids, tissues, and blood and is used as a marker for a good or unhealthy process or for a disease like cancer, according to the National Cancer Institute. A patient with an ailment can be distinguished from a healt...
Progress in active specific immunotherapy of prostate cancer Benjamin A. Tjoa,Gerald P. Murphy - 《Seminars in Surgical Oncology》 - 2000 - 被引量: 147 Prostate cancer antigen-1 as a potential novel marker fo...
Mutant L Homologue 1 (MLH1): a possible new immunohistochemical marker for prostatic cancer Aims: Combined hepatocellular cholangiocarcinoma (CHC) is a rare form of primary liver cancer, showing a mixture of hepatocellular and biliary features. Da... S㏕ Chuang,B Adley,M Han,... - 《Histopatho...
Reliable prognostic biomarkers to distinguish indolent from aggressive prostate cancer (PCa) are lacking. Many studies investigated microRNAs (miRs) as PCa prognostic biomarkers, often reporting inconsistent findings. We present a systematic review of these; also systematic reanalysis of public miR-profile...
Non-B DNA-informed mutation burden as a marker of treatment response and outcome in cancer Qi Xu &Jeanne Kowalski Article 14 October 2024|Open Access Identification of a 5-gene signature panel for the prediction of prostate cancer progression ...
MARKER GENES FOR PROSTATE CANCER CLASSIFICATIONThe present invention relates to a method for classifying a prostate cancer in a subject, the method comprising the steps of a) determining a gene expression level or gene expression pattern of the genes F3 and IGFBP3 in a sample from the subject ...